secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELITE PHARMACEUTICALS INC /NV/ (ELTP)
CIK:        0001053369
Form:       8-K
Filed at:   2024-12-02T23:59:59+00:00
Accession:  0001493152-24-048294
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elite Pharmaceuticals launches generic Norco (hydrocodone/acetaminophen) tablets
--------------------------------------------------------------------------------

- Launched generic Norco (hydrocodone bitartrate/acetaminophen) in 2.5/325, 5/325, 7.5/325, and 10/325 mg strengths.
- Indicated for management of pain severe enough to require an opioid analgesic when alternatives are inadequate.
- IQVIA reported annual sales of approximately $300M for the brand product for 12 months ending September 2024.
- Product marketed and sold under the Elite Laboratories label.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053369/000149315224048294/0001493152-24-048294-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053369/000149315224048294/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-048294

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer